Skip to main content

Table 1 Baseline characteristics of military personnel with HIV

From: Association between quantitative varicella-zoster virus antibody levels and zoster reactivation in HIV-infected persons

Characteristics

All

N = 300

Cases

N = 100

Control

N = 200

p-value

Median age at HIV diagnosis (years)

28.35

28.35

28.25

0.978

Median time HIV negative to positive (years)

0.68

0.66

0.69

0.828

Median time HIV diagnosis to 1st ART (years)

5.41

5.78

4.82

0.078

Gender

   

0.611

 Male

282 (94%)

94 (94%)

188 (94%)

 

 Female

18 (6%)

6 (6%)

12 (6%)

 

Race/ethnicity

   

0.024

 Caucasian

134 (44.7%)

47 (47%)

87 (43.5%)

 

 African–American

123 (41%)

36 (36%)

87 (43.5%)

 

 Hispanic/Puerto Rican/Mexican

28 (9.3%)

13 (13%)

15 (7.5%)

 

 Asian/Pacific Islander

5 (1.7%)

0

5 (2.5%)

 

 Native American/Alaskan Native

3 (3%)

3 (3%)

0

 

 Other

7 (2.3%)

1 (1%)

6 (3%)

 

Median time HIV diagnosis to last study visit (years)

13.18

14.28

13.0384

0.201

Median time from HIV diagnosis to 1st serum date (years)

2.18

1.38

2.53

0.009

Median time from HIV diagnosis to 2nd serum date (years)

6.89

6.98

6.81

0.975

Median CD4 at 1st serum date (cells/μL)

530

534.5

523

0.940

Median VL at 1st serum date (log10 copies/mL)

3.66

3.72

3.65

0.471

Median CD4 at 2nd serum date (cells/μL)

501

436

527

0.007

Median VL at 2nd serum date (log10 copies/mL)

2.80

3.52

2.60

0.007

On ART at 1st serum date

   

0.075

 No

201 (67%)

73 (73%)

128 (64%)

 

 Yes

99 (33%)

27 (27%)

72 (36%)

 

On ART at 2nd serum date

   

0.025

 No

119 (39.7%)

48 (48%)

71 (35.5%)

 

 Yes

181 (60.3%)

52 (52%)

129 (64.5%)